Blog
About

0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum]

      International Journal of Chronic Obstructive Pulmonary Disease

      Dove

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Li H, Zeng Z, Cheng J, et al. Int J Chron Obstructive Pulm Dis. 2020;15:57–67. On page 63, Figures 3 is incorrect, the authors missed to check the correct revised figures were inserted into the manuscript during the revision process. The correct figures are as below: Figure 3 Kaplan–Meier survival curves evaluating the time to death in days for patients with NT-proBNP concentrations ≥551.35 ng/L and NT-proBNP concentrations <551.35 ng/L. Panel A: survival curve for all patients; Panel B: survival curve for patients with CHF; Panel C: survival curve for patients without CHF. Abbreviation: CHF, congestive heart failure.

          Related collections

          Author and article information

          Journal
          Int J Chron Obstruct Pulmon Dis
          Int J Chron Obstruct Pulmon Dis
          COPD
          copd
          International Journal of Chronic Obstructive Pulmonary Disease
          Dove
          1176-9106
          1178-2005
          03 February 2020
          2020
          03 February 2020
          : 15
          : 247-248
          Article
          246084
          10.2147/COPD.S246084
          7007496
          © 2020 Li et al.

          This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

          Page count
          Pages: 2
          Categories
          Corrigendum

          Respiratory medicine

          Comments

          Comment on this article